Pfizer Balance Sheet Health
Financial Health criteria checks 3/6
Pfizer has a total shareholder equity of $92.6B and total debt of $67.9B, which brings its debt-to-equity ratio to 73.4%. Its total assets and total liabilities are $219.5B and $126.9B respectively. Pfizer's EBIT is $11.5B making its interest coverage ratio 7.1. It has cash and short-term investments of $10.0B.
Key information
73.4%
Debt to equity ratio
US$67.95b
Debt
| Interest coverage ratio | 7.1x |
| Cash | US$9.95b |
| Equity | US$92.56b |
| Total liabilities | US$126.92b |
| Total assets | US$219.48b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PFE's short term assets ($43.2B) exceed its short term liabilities ($43.2B).
Long Term Liabilities: PFE's short term assets ($43.2B) do not cover its long term liabilities ($83.7B).
Debt to Equity History and Analysis
Debt Level: PFE's net debt to equity ratio (62.7%) is considered high.
Reducing Debt: PFE's debt to equity ratio has reduced from 80.5% to 73.4% over the past 5 years.
Debt Coverage: PFE's debt is not well covered by operating cash flow (16.6%).
Interest Coverage: PFE's interest payments on its debt are well covered by EBIT (7.1x coverage).